These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. More dimensions for glutamate toxicity. Barnes DM Science; 1988 Dec; 242(4885):1509-10. PubMed ID: 2904700 [No Abstract] [Full Text] [Related]
5. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Carlsson M; Carlsson A Schizophr Bull; 1990; 16(3):425-32. PubMed ID: 1981107 [TBL] [Abstract][Full Text] [Related]
6. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Konradi C; Heckers S Pharmacol Ther; 2003 Feb; 97(2):153-79. PubMed ID: 12559388 [TBL] [Abstract][Full Text] [Related]
7. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease? Lawlor BA; Davis KL Biol Psychiatry; 1992 Feb; 31(4):337-50. PubMed ID: 1348429 [TBL] [Abstract][Full Text] [Related]
8. Hyperinnervation of orbital frontal cortex in schizophrenia. Deakin JF; Slater P; Simpson MD; Royston MC Br J Psychiatry; 1990 Sep; 157():459-60. PubMed ID: 1978787 [No Abstract] [Full Text] [Related]
18. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Simpson MD; Slater P; Royston MC; Deakin JF Psychiatry Res; 1992 Jun; 42(3):273-82. PubMed ID: 1353892 [TBL] [Abstract][Full Text] [Related]
19. The use of anti-idiotypic antibodies as a strategy for studying glutamate receptors. Duce IR; Budd TC; Richardson PJ Biochem Soc Trans; 1991 Feb; 19(1):143-6. PubMed ID: 1645307 [No Abstract] [Full Text] [Related]
20. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Krystal JH; Anand A; Moghaddam B Arch Gen Psychiatry; 2002 Jul; 59(7):663-4. PubMed ID: 12090822 [No Abstract] [Full Text] [Related] [Next] [New Search]